Tumor-specific mRNA in cell-free bronchial lavage supernatant - new possibilities in lung cancer diagnosis Source: Eur Respir J 2003; 22: Suppl. 45, 363s Year: 2003
Comparative evaluation of the diagnostic value of serum tumor markers versus those identified in bronchial lavage fluid in patients with histologically confirmed bronchial carcinoma Source: Eur Respir J 2003; 22: Suppl. 45, 256s Year: 2003
Validation of diagnostic molecular markers in bronchial fluid for lung cancer Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer Year: 2011
Detection of MAGE-A expression in induced sputum and bronchial lavage fluid of patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 362s Year: 2003
Diagnostic value of tumor markers and cells population in bronchoalveolar lavage in lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 37s Year: 2003
Potential lung cancer biomarkers from bronchoalveolar lavage fluid using metabolomics approaches Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016
Early detection of lung cancer: role of biomarkers Source: Eur Respir J 2003; 21: 36S-44S Year: 2003
Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011
Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients? Source: Eur Respir J 2015; 46: 1548-1550 Year: 2015
Comparative metabolomic study of lung cancer based on serum, urine and bronchoalveolar lavage fluid. Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017
BALF immune profile - towards clinical usefulness in lung cancer. Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer Year: 2019
Lung cancer detection by computer assisted analysis of novel biomarkers in induced sputum samples Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008
Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013
Serum and bronchial aspiration fluid HE-4 levels in lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015
Impaired expression of telomerase activity in bronchoalveolar lavage fluid cells in patients with lung cancer: Preliminary results Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference? Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013
The detection of quantitative serum p53 protein in lung cancer and its clinical value Source: Eur Respir J 2003; 22: Suppl. 45, 363s Year: 2003
Tumour markers in bronchoalveolar lavage and its diagnostic contribution in lung cancer not visible through regular fibrobronchoscopy Source: Eur Respir J 2002; 20: Suppl. 38, 276s Year: 2002
Comparative analysis of surface antigen expression and DNA content in circulating, tissue and bronchoalveolar lavage lymphocytes in patients with COPD after radiation exposure Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002
The diagnostic value of bronchoalvolar lavage (BAL) in the diagnosis of peripheral lung cancer (PLC) Source: Eur Respir J 2003; 22: Suppl. 45, 253s Year: 2003